Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-011946

Options or other derivatives

  • Chief Business Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Zimmermann Carolyne · Chief Business Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +60,000 60,000 D
Loading xslF345X03/doc1.xml…